 | Up a level |
Journal Article
Bloos, Frank 
ORCID: 0000-0002-0767-7941, Held, Juergen, Schlattmann, Peter, Brillinger, Nicole, Kurzai, Oliver, Cornely, Oliver A. and Thomas-Rueddel, Daniel
(2018).
(1,3)-beta-D-glucan-based diagnosis of invasive Candida infection versus culturebased diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
Trials, 19.
LONDON:
BMC.
ISSN 1745-6215
Hagel, Stefan ORCID: 0000-0003-2999-6131, Fiedler, Sandra, Hohn, Andreas, Brinkmann, Alexander, Frey, Otto R., Hoyer, Heike, Schlattmann, Peter, Kiehntopf, Michael, Roberts, Jason A., Pletz, Mathias W., Bloos, Frank, Angermair, Stefan, Bracht, Hendrik, Barth, Eberhard, Kluge, Stefan, Nierhaus, Axel, Motsch, Johann, Brenner, Thorsten, Annecke, Thorsten ORCID: 0000-0002-2496-4432, Bach, Friedhelm, Weigand, Markus, Schappacher, Markus, von Ameln-Mayerhofer, Andreas, Michels, Guido, Roehr, Anka, Fuchs, Thomas, Eichner, Sarah, Barth, Eberhard, Kong, Christina, Pinder, Nadine, Mueller, Carsten, Petersen, Miriam, Schlattmann, Peter, Steinbach, Gerald, Jarczak, Dominik, Weisman, Dirk, Kurlbaum, Max and Braune, Anke
(2019).
Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
Trials, 20.
LONDON:
BMC.
ISSN 1745-6215